Australia - English - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - lopinavir, quantity: 100 mg; ritonavir, quantity: 25 mg - tablet, film coated - excipient ingredients: titanium dioxide; polyvinyl alcohol; macrogol 3350; purified talc; colloidal anhydrous silica; iron oxide yellow; copovidone; sorbitan monolaurate; sodium stearylfumarate - kaletra is indicated for the treatment of hiv-1 infection, in combination with other antiretroviral agents in adults and children aged 2 years and older. this indication is based on the analyses of plasma hiv-1 rna levels and cd4 cell counts from controlled clinical studies (see clinical trials).

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - lopinavir 100mg; ritonavir 25mg;   - film coated tablet - 100mg/25mg - active: lopinavir 100mg ritonavir 25mg   excipient: colloidal silicon dioxide copovidone opadry white 20c580015 sodium stearyl fumarate sorbitan laurate - lopinavir/ritonavir mylan is indicated for the treatment of hiv-1 infection, in combination with other antiretroviral agents in adults and children aged 2 years and older.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - lopinavir 200mg; ritonavir 50mg;   - film coated tablet - 200mg/50mg - active: lopinavir 200mg ritonavir 50mg   excipient: colloidal silicon dioxide copovidone opadry white 20c580015 sodium stearyl fumarate sorbitan laurate - lopinavir/ritonavir mylan is indicated for the treatment of hiv-1 infection, in combination with other antiretroviral agents in adults and children aged 2 years and older.

Namibia - English - Namibia Medicines Regulatory Council

abbvie (pty) ltd - lopinavir, ritonavir - tablet - each film-coated tablet contains lopinavir 100,0 mg , ritonavir 25,0 mg

Namibia - English - Namibia Medicines Regulatory Council

matrix laboratories ltd - lopinavir, ritonavir - tablet - each film-coated tablet contains lopinavir 100,0 mg , ritonavir 25,0 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - lopinavir, quantity: 200 mg; ritonavir, quantity: 50 mg - tablet, film coated - excipient ingredients: sodium stearylfumarate; macrogol 3350; hyprolose; macrogol 400; colloidal anhydrous silica; polysorbate 80; purified talc; copovidone; titanium dioxide; iron oxide yellow; hypromellose; sorbitan monolaurate - kaletra is indicated for the treatment of hiv-1 infection, in combination with other antiretroviral agents in adults and children aged 2 years and older. this indication is based on the analyses of plasma hiv-1 rna levels and cd4 cell counts from controlled clinical studies (see clinical trials).

Israel - English - Ministry of Health

abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - film coated tablets - lopinavir 100 mg; ritonavir 25 mg - ritonavir - ritonavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infections.

Singapore - English - HSA (Health Sciences Authority)

abbvie pte. ltd. - ritonavir - tablet, film coated - 100.0 mg - ritonavir 100.0 mg

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - ritonavir - film coated tablet - 100 base milligrams - ritonavir

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - ritonavir - film-coated tablet - 100 milligram(s) - protease inhibitors; ritonavir